BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37864025)

  • 1. Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status.
    Li X; Fan Z; Jiang H; Niu J; Bian W; Wang C; Wang Y; Zhang R; Zhang H
    Sci Rep; 2023 Oct; 13(1):17978. PubMed ID: 37864025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of synthetic MRI in differential diagnosis of benign and malignant breast lesions].
    Che SN; Li J; Xue M; Song Y; Zhao LY; Guo N; Tian Y; Xie LZ; Zhao XM; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):872-877. PubMed ID: 34407594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential diagnosis of benign and malignant breast lesions using quantitative synthetic magnetic resonance imaging].
    Zhang L; Zhao X; Yin X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):457-462. PubMed ID: 35527481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding quantitative T1rho-weighted imaging to conventional MRI improves specificity and sensitivity for differentiating malignant from benign breast lesions.
    Wang L; Wang X; Jiang F; Cao Y; Liu S; Chen H; Yang J; Zhang X; Yu T; Xu H; Lin M; Wu Y; Zhang J
    Magn Reson Imaging; 2024 May; 108():98-103. PubMed ID: 38331054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
    Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
    Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of synthetic MRI with quantitative parameters for discriminating axillary lymph nodes status in invasive breast cancer.
    Qu M; Feng W; Liu X; Li Z; Li Y; Lu X; Lei J
    Eur J Radiol; 2024 Jun; 175():111452. PubMed ID: 38604092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images.
    Kanao S; Kataoka M; Iima M; Ikeda DM; Toi M; Togashi K
    Magn Reson Imaging; 2018 Jul; 50():38-44. PubMed ID: 29545213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI.
    Meng T; He N; He H; Liu K; Ke L; Liu H; Zhong L; Huang C; Yang A; Zhou C; Qian L; Xie C
    Cancer Imaging; 2020 Dec; 20(1):88. PubMed ID: 33317609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole Volume Apparent Diffusion Coefficient (ADC) Histogram as a Quantitative Imaging Biomarker to Differentiate Breast Lesions: Correlation with the Ki-67 Proliferation Index.
    Guo Y; Kong QC; Li LQ; Tang WJ; Zhang WL; Ning GY; Xue J; Zhou QW; Liang YY; Wu M; Jiang XQ
    Biomed Res Int; 2021; 2021():4970265. PubMed ID: 34258262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
    Xiang Y; Zhang Q; Chen X; Sun H; Li X; Wei X; Zhong J; Gao B; Huang W; Liang W; Sun H; Yang Q; Ren X
    Eur Radiol; 2024 Mar; ():. PubMed ID: 38491129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
    Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
    Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic MRI, multiplexed sensitivity encoding, and BI-RADS for benign and malignant breast cancer discrimination.
    Liu J; Xu M; Ren J; Li Z; Xi L; Chen B
    Front Oncol; 2022; 12():1080580. PubMed ID: 36818669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative predicting malignancy in breast mass-like lesions: value of adding histogram analysis of apparent diffusion coefficient maps to dynamic contrast-enhanced magnetic resonance imaging for improving confidence level.
    Liu HL; Zong M; Wei H; Lou JJ; Wang SQ; Zou QG; Shi HB; Jiang YN
    Br J Radiol; 2017 Nov; 90(1079):20170394. PubMed ID: 28876982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the ADC ratio in the differential diagnosis of breast lesions.
    Zhao J; Guan H; Li M; Gu H; Qin J; Wu X
    Acta Radiol; 2016 Apr; 57(4):422-9. PubMed ID: 26071495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
    Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
    J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast.
    Ao F; Yan Y; Zhang ZL; Li S; Li WJ; Chen GB
    Acta Radiol; 2022 Jul; 63(7):891-900. PubMed ID: 34134527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
    Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
    J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.